TalkMed (SGX: 5G3)

0.405 CD

-0.005 (-1.22%)
Range 0.405 - 0.405   (-%)
Open 0.405
Previous Close 0.410
Buy Price 0.405
Buy Volume 0.8
Sell Price 0.415
Sell Volume 4.1
Volume 20
Value 8,100
Remark CD
Measurement Type Value
EPS (SGD) 0.023
Trailing EPS (SGD) 0.023
NAV (SGD) 0.067
Cash In Hand (SGD) 0.061
Dividend 0.03
Dividend Yield (%) 7.306
PE 17.78
Trailing PE 17.777
Price / NAV 6.119
Price / Cash In Hand 6.743
Issued & Paid-up Shares 1,324,500,000
Treasury Shares -
Market Cap (M) 543.045
Par Value (SGD) n.a.
Beta - 75 Days -0.041
R-Squared - 75 Days(%) 0.02
Beta - 500 Days 0.183
R-Squared - 500 Days(%) 0.77
ISIN Code SG2G61000003
Under CPF Investment Scheme (CPFIS) No
Index Components FTSE ST Catalist Index
Delayed prices. Updated at 20 Mar 2023 16:52.
Data powered by

Upcoming Events

Dividend

Ex-Date 28 Apr 2023
Record Date 02 May 2023
Payable Date 11 May 2023
Rate: SGD 0.015 Per Security
Data powered by SGX.
View Stock Calendar
View All Events

About TalkMed

TalkMed Group Limited is a Singapore-based investment holding company. The Company's principal activities are the provision of medical oncology services and stem cell transplant services. The Company's segments include Oncology services and Stem cells services. Its doctors provide tertiary healthcare services in the fields of medical oncology, stem cell transplant and palliative care to the oncology patients in the private sector in Singapore through Parkway Cancer Centre (PCC). Its clinical functions include attending to patients, examination and administering medical treatment to patients and performing minor outpatient surgical procedures, prescribing medicines and investigations, such as laboratory tests or diagnostic procedures. These clinical functions also include the review of investigation results and follow-up care with the patient. It provides medical oncology services and palliative care services with approximately 13 doctors at over eight clinics.

Loading Chart...